These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 13680537)

  • 21. Pathophysiology of renal tissue damage by iodinated contrast media.
    Sendeski MM
    Clin Exp Pharmacol Physiol; 2011 May; 38(5):292-9. PubMed ID: 21348890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Et-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia.
    Liss P; Carlsson PO; Nygren A; Palm F; Hansell P
    Acta Radiol; 2003 Jan; 44(1):111-7. PubMed ID: 12631011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the pathogenesis and prevention of contrast-induced nephropathy.
    Zhang F; Lu Z; Wang F
    Life Sci; 2020 Oct; 259():118379. PubMed ID: 32890604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequently asked questions: iodinated contrast agents.
    Bettmann MA
    Radiographics; 2004 Oct; 24 Suppl 1():S3-10. PubMed ID: 15486247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal failure and iodinated contrast media. A review.
    Violon D
    JBR-BTR; 1999 Apr; 82(2):57-62. PubMed ID: 10874391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evidence-based approach to minimise contrast-induced nephropathy.
    Darwish T
    N Z Med J; 2009 Jul; 122(1299):39-41. PubMed ID: 19684646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of contrast-induced nephropathy.
    Wong PC; Li Z; Guo J; Zhang A
    Int J Cardiol; 2012 Jul; 158(2):186-92. PubMed ID: 21784541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies.
    Faucon AL; Bobrie G; Clément O
    Eur J Radiol; 2019 Jul; 116():231-241. PubMed ID: 31054788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is dialysis efficient in the prevention of ionic contrast agent-induced nephropathy?].
    Karie S; Launay-Vacher V; Izzedine H; Deray G
    Presse Med; 2005 Jun; 34(11):803-8. PubMed ID: 16097384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioconstrast nephropathy].
    Durdević-Mirković T; Curić S; Vodopivec S; Mitić I; Bozić D; Petrović L; Ilić T
    Med Pregl; 2002; 55(7-8):333-6. PubMed ID: 12434682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-induced kidney injury: mechanisms, risk factors, and prevention.
    Seeliger E; Sendeski M; Rihal CS; Persson PB
    Eur Heart J; 2012 Aug; 33(16):2007-15. PubMed ID: 22267241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcysteine for radiocontrast nephropathy.
    Tepel M; Zidek W
    Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy.
    Elicker BM; Cypel YS; Weinreb JC
    AJR Am J Roentgenol; 2006 Jun; 186(6):1651-8. PubMed ID: 16714655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Christin A; Fumeaux T
    Rev Med Suisse; 2017 May; 13(561):972. PubMed ID: 28631448
    [No Abstract]   [Full Text] [Related]  

  • 36. Does iodinated radiocontrast material pose an appreciable risk for kidney injury in the critically ill?
    Quartin AA; Schein RM; Cely CM
    Crit Care Med; 2013 Nov; 41(11):e387-8. PubMed ID: 24162691
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiocontrast-induced acute kidney injury.
    McCullough PA
    Nephron Physiol; 2008; 109(4):p61-72. PubMed ID: 18802377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nephrotoxicity due to iodine contrasts in computerized tomography studies of diabetic outpatients on metformin].
    Gómez Herrero H; De Arriba Villamor C; Buldain Parra M; Arraiza Sarasa M
    An Sist Sanit Navar; 2013 Sep; 36(2):197-201. PubMed ID: 24008523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of radiocontrast nephropathy.
    Lin J; Bonventre JV
    Curr Opin Nephrol Hypertens; 2005 Mar; 14(2):105-10. PubMed ID: 15687835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contrast-media-induced nephrotoxicity].
    Adolph E; Chatterjee T; Ince H; Eckard H; Rehders T; Kische S; Drawert S; Petzsch M; Nienaber CA
    Dtsch Med Wochenschr; 2005 Oct; 130(42):2391-6. PubMed ID: 16235148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.